4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0001209191-22-041333
Options or other derivatives
- Chief Operating Officer acquired 36,219 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| HIGH SUSANNA GATTI Chief Operating Officer | 2022-07-05 | Grant or award · Stock Option (right to buy) | +36,219 | 36,219 | D | ||
Loading xslF345X03/doc4.xml…